Author:
Zainullina L. F.,Ivanova T. V.,Ostrovskaya R. U.,Gudasheva T. A.,Vakhitova Yu. V.,Seredenin S. B.
Publisher
Springer Science and Business Media LLC
Subject
General Biochemistry, Genetics and Molecular Biology,General Medicine
Reference14 articles.
1. Andreeva NA, Stel’mashuk EV, Isaev NK, Ostrovskaya RU, Gudasheva TA, Viktorov IV. Neuroprotective properties of nootropic dipeptide GVS-111 in in vitro oxygen-glucose deprivation, glutamate toxicity and oxidative stress. Bull. Exp. Biol. Med. 2000;130(10):969-972.
2. Antipova TA, Nikolaev SV, Ostrovskaya PU, Gudasheva TA, Seredenin SB. Dipeptide Piracetam Analogue Noopept Improves Viability of Hippocampal HT-22 Neurons in the Glutamate Toxicity Model. Bull. Exp. Biol. Med. 2016;161(1):58-60.
3. Vakhitova YV, Sadovnikov SV, Borisevich SS, Ostrovskaya RU, Gudasheva TA, Seredenin SB. Molecular mechanism underlying the action of substituted Pro-Gly dipeptide Noopept. Acta Naturae. 2016;8(1):82-89.
4. Ostrovskaya RU, Vakhitova YuV, Salimgareeva MKh, Yamidanov RS, Sadovnikov SV, Kapitsa IG, Seredenin SB. On the mechanism of Noopept action: decrease in activity of stressinduced kinases and increase in expression of neutrophines. Eksp. Klin. Farmakol. 2010;73(12):2-5. Russian.
5. Ostrovskaya RU, Gudasheva TA, Voronina TA, Seredenin SB. The novel nootropic and neuroprotector drug Noopept (GVS-111). Eksp. Klin. Farmakol. 2002;65(5):66-72. Russian.